• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一种测定慢性肾功能不全患者血清中中分子肽的定量方法]

[A quantitative method of determining middle molecule peptides in the blood serum of patients with chronic renal insufficiency].

作者信息

Salikhova N N, Akhmedzhanov R I, Mukhamadieva Sh G, Sakhibov A D

出版信息

Lab Delo. 1989(3):48-52.

PMID:2469841
Abstract

Gel chromatography and high performance liquid chromatography have been applied to analysis of the blood serum peptides in renal patients. The levels of the peptides with a molecular mass of 300-5000 D have been found to correlate with the severity of the kidney involvement. A rapid method for measuring the concentrations of these peptides has been developed, based on the precipitation of the blood serum high-molecular peptides followed by measurement of the concentration of the peptides remaining in the supernatant with the use of a specific reagent. The suggested method has been used to define the severity of the kidney involvement and to monitor the efficacy of hemodialysis and hemoperfusion.

摘要

凝胶色谱法和高效液相色谱法已应用于肾病患者血清肽的分析。已发现分子量为300 - 5000 D的肽水平与肾脏受累的严重程度相关。基于血清高分子肽的沉淀,随后使用特定试剂测量上清液中剩余肽的浓度,开发了一种快速测量这些肽浓度的方法。所建议的方法已用于确定肾脏受累的严重程度,并监测血液透析和血液灌流的疗效。

相似文献

1
[A quantitative method of determining middle molecule peptides in the blood serum of patients with chronic renal insufficiency].[一种测定慢性肾功能不全患者血清中中分子肽的定量方法]
Lab Delo. 1989(3):48-52.
2
[The evaluation of the efficacy of efferent therapy in patients with acute and chronic kidney failure by the spectrum of blood middle-molecule fractions].[通过血液中分子组分谱评估传出疗法对急慢性肾衰竭患者的疗效]
Urol Nefrol (Mosk). 1994 Jul-Aug(4):35-7.
3
[Effect of hemodialysis and hemosorption on blood serum level of medium-molecular components in patients with chronic renal failure].
Ter Arkh. 1984;56(7):77-81.
4
[Approach to elaborating immunochemical methods for removing peptides from the blood of kidney failure patients].[阐述用于清除肾衰竭患者血液中肽的免疫化学方法的途径]
Biull Eksp Biol Med. 1984 Aug;98(8):245-7.
5
Increased plasma guanylin levels in patients with impaired renal function.肾功能受损患者血浆鸟苷素水平升高。
Clin Nephrol. 1997 Jan;47(1):28-32.
6
Serum lipid concentrations correlate with the progression of chronic renal failure.血清脂质浓度与慢性肾衰竭的进展相关。
Clin Lab Sci. 1999 Mar-Apr;12(2):104-8.
7
[Concentration of middle-sized molecules in the blood of children with chronic renal failure during treatment with short-term hemodialysis].[短期血液透析治疗期间慢性肾衰竭患儿血液中中分子物质的浓度]
Vopr Med Khim. 1980 Nov-Dec;26(6):742-6.
8
Plasma concentration of human adrenomedullin in patients on hemodialysis.血液透析患者的人肾上腺髓质素血浆浓度。
Clin Nephrol. 1995 Dec;44(6):389-93.
9
Cardiac troponins have no prognostic value for acute and chronic cardiac events in asymptomatic patients with end-stage renal failure.对于终末期肾衰竭无症状患者的急性和慢性心脏事件,心肌肌钙蛋白没有预后价值。
Clin Nephrol. 2001 Jul;56(1):44-51.
10
Serum levels of polyamines in patients with chronic renal failure.慢性肾衰竭患者的血清多胺水平。
Kidney Int Suppl. 1983 Dec;16:S234-7.